CYBIN INC. - HELP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 10, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.0% | 2,514,667 | View |
| Apr 10, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.0% | 2,514,667 | View |
| Apr 10, 2026 | SCHEDULE 13G | Israel A. Englander | 5.0% | 2,514,667 | View |
| Mar 26, 2026 | SCHEDULE 13G | Millennium Management LLC | 4.8% | 2,397,721 | View |
| Mar 26, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 4.8% | 2,397,721 | View |
| Mar 26, 2026 | SCHEDULE 13G | Israel A. Englander | 4.8% | 2,397,721 | View |
| Feb 17, 2026 | SCHEDULE 13G | ORBIMED ADVISORS LLC | 2.8% | 1,417,900 | View |
| Feb 17, 2026 | SCHEDULE 13G | ORBIMED CAPITAL LLC | 4.9% | 2,422,600 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | KEVIN TANG | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 4.74% | 2,391,505 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 4.74% | 2,391,505 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Kroin | 4.74% | 2,391,505 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 9.9% | 6,410,778 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 9.9% | 6,410,778 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven A. Cohen | 9.9% | 6,410,778 | View |
| Nov 07, 2025 | SCHEDULE 13G | Venrock Healthcare Capital Partners III, L.P. | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | VHCP Co-Investment Holdings III, LLC | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | VHCP Management III, LLC | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | VHCP Management EG, LLC | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | Nimish Shah | 9.9% | 5,111,412 | View |
| Nov 07, 2025 | SCHEDULE 13G | Bong Y. Koh | 9.9% | 5,111,412 | View |
| Nov 04, 2025 | SCHEDULE 13G | Deep Track Capital, LP | 6.09% | 3,072,250 | View |
| Nov 04, 2025 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 6.09% | 3,072,250 | View |
| Nov 04, 2025 | SCHEDULE 13G | David Kroin | 6.09% | 3,072,250 | View |
| Oct 29, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 3.97% | 1,000,000 | View |
| Oct 29, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 3.97% | 1,000,000 | View |
| Oct 29, 2025 | SCHEDULE 13G/A | David Kroin | 3.97% | 1,000,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.